Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Vaccines|July 27, 2024
Serosurveillance for Measles and RubellaAllison M Brady, Elina El-Badry, Eriko Padron-Regalado, et al.Journal of Virology|May 29, 2020
Better Viral Control despite Higher CD4+ T Cell Activation during Acute HIV-1 Infection in Zambian Women Is Linked to the Sex Hormone EstradiolElina El-Badry, Gladys Macharia, Daniel Claiborne, et al.Frontiers in Immunology|February 4, 2025
Heightened expression of type I interferon signaling genes in CD4+ T cells from acutely HIV-1-infected women is associated with lower viral loadsElina El-Badry, Luxiao Chen, Khader Ghneim, et al.Frontiers in Microbiology|August 27, 2025
Comparison of viral phenotype and inflammatory biomarker responses in acute HIV-1 subtype A and C infectionsSamantha McInally, Daniel T Claiborne, Elina El-Badry, et al.Open Forum Infectious Diseases|January 12, 2024
Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses Among Adults With 3 Doses of Measles-Mumps-Rubella VaccineOluwakemi D Alonge, Mona Marin, Carole J Hickman, et al.The Journal of Infectious Diseases|July 8, 2026
Seroprevalence of Measles, Mumps, Rubella, and Varicella-Zoster Virus Antibodies-United States, 2017-March 2020Chelsea S Lutz, Patricia Castro-Roman, Mona Marin, et al.Lancet (London, England)|May 2, 2024
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trialIkechukwu Adigweme, Mohammed Yisa, Michael Ooko, et al.Pageof 1